Expert Interview
Discussing protein degraders in the oncology space
Ticker(s): ARVN, CCCC, NRIX, KYMRAssistant Professor in the division of Chemical Biology and Medicinal Chemistry in the Eshelman School of Pharmacy. Her laboratory integrates expertise in organic chemistry, medicinal chemistry, chemical biology, and chromatin biology in order to discover novel epigenetic inhibitors, while applying these inhibitors to develop an improved understanding of chromatin regulation and better define the role of epigenetic proteins in disease. She is also the Director of Chemical Biology within the Center for Integrative Chemical Biology and Drug Discovery (CICBDD) where she collaborates closely with UNC faculty from various departments to provide medicinal chemistry and chemical biology expertise to bear on biological targets of therapeutic relevance. She received her Ph.D. in chemistry from UNC.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
